BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 22578371)

  • 21. Management of major bleedings during anticoagulant treatment with the oral direct thrombin inhibitor ximelagatran or warfarin.
    Fernlöf G; Sjöström BM; Lindell KM; Wall UE
    Blood Coagul Fibrinolysis; 2009 Dec; 20(8):667-74. PubMed ID: 19741508
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reversal of warfarin-induced coagulopathy: review of treatment options.
    Hall AB; Carson BC
    J Emerg Nurs; 2012 Jan; 38(1):98-101. PubMed ID: 21474171
    [No Abstract]   [Full Text] [Related]  

  • 23. Perceptions about time for normalization of international normalized ratio in patients requiring acute warfarin reversal when using fresh-frozen plasma.
    Jones CA; Petrozzino JJ; Hoesche J; Krol EM; Freeman K
    Am J Emerg Med; 2013 May; 31(5):878-9. PubMed ID: 23478117
    [No Abstract]   [Full Text] [Related]  

  • 24. Comments on the outcomes of prothrombin complex concentrates in warfarin-associated intracranial hemorrhage.
    Peled H; Nguyen LH
    Neurocrit Care; 2014 Oct; 21(2):369-70. PubMed ID: 24969028
    [No Abstract]   [Full Text] [Related]  

  • 25. Response to letter to the editor: prothrombin complex concentrates in warfarin-associated intracranial hemorrhage.
    Frontera JA
    Neurocrit Care; 2014 Oct; 21(2):371. PubMed ID: 24985499
    [No Abstract]   [Full Text] [Related]  

  • 26. [Prothrombin complex concentrate good in warfarin induced hemorrhage. Quick reversal--plasma should be avoided].
    Själander A; Berntorp E; Svensson PJ
    Lakartidningen; 2009 Sep 9-15; 106(37):2278, 2280-1. PubMed ID: 19817161
    [No Abstract]   [Full Text] [Related]  

  • 27. [Hemorrhagic complications during warfarin treatment].
    Gumulec J; Kessler P; Penka M; Klodová D; Králová S; Brejcha M; Wróbel M; Sumná E; Blatný J; Klaricová K; Riedlová P; Lasota Z
    Vnitr Lek; 2006 Mar; 52 Suppl 1():79-91. PubMed ID: 16637455
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reversing the Effect of Oral Anticoagulant Drugs: Established and Newer Options.
    Ansell JE
    Am J Cardiovasc Drugs; 2016 Jun; 16(3):163-70. PubMed ID: 26872887
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reversal Agents for the Direct Oral Anticoagulants.
    Ansell JE
    Hematol Oncol Clin North Am; 2016 Oct; 30(5):1085-98. PubMed ID: 27637309
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prothrombin complex concentrate versus standard therapies for INR reversal in trauma patients receiving warfarin.
    Chapman SA; Irwin ED; Beal AL; Kulinski NM; Hutson KE; Thorson MA
    Ann Pharmacother; 2011 Jul; 45(7-8):869-75. PubMed ID: 21775690
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Experience with prothrombin complex for the emergent reversal of anticoagulation in rural geriatric trauma patients.
    Quick JA; Bartels AN; Coughenour JP; Barnes SL
    Surgery; 2012 Oct; 152(4):722-6; discussion 726-8. PubMed ID: 22943840
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anticoagulants and their reversal.
    Schulman S; Bijsterveld NR
    Transfus Med Rev; 2007 Jan; 21(1):37-48. PubMed ID: 17174219
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Major bleeding with old and novel oral anticoagulants: How to manage it. Focus on reversal agents.
    Di Fusco SA; Lucà F; Benvenuto M; Iorio A; Fiscella D; D'Ascenzo F; Madeo A; Colivicchi F; Di Lenarda A; Gulizia MM
    Int J Cardiol; 2018 Oct; 268():75-79. PubMed ID: 29843897
    [TBL] [Abstract][Full Text] [Related]  

  • 34. What to do when warfarin therapy goes too far.
    Prasad S; Wootten MR; Kulinski N; Chapman SA
    J Fam Pract; 2009 Jul; 58(7):346-52. PubMed ID: 19607771
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reversal of warfarin: case-based practice recommendations.
    Garcia DA; Crowther MA
    Circulation; 2012 Jun; 125(23):2944-7. PubMed ID: 22689931
    [No Abstract]   [Full Text] [Related]  

  • 36. New strategies for effective treatment of vitamin K antagonist-associated bleeding.
    Yates SG; Sarode R
    J Thromb Haemost; 2015 Jun; 13 Suppl 1():S180-6. PubMed ID: 26149021
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reversal of Anticoagulation and Management of Bleeding in Patients on Anticoagulants.
    Dhakal P; Rayamajhi S; Verma V; Gundabolu K; Bhatt VR
    Clin Appl Thromb Hemost; 2017 Jul; 23(5):410-415. PubMed ID: 27789605
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fresh frozen plasma dosing for warfarin reversal: a practical formula.
    Rashidi A; Tahhan HR
    Mayo Clin Proc; 2013 Mar; 88(3):244-50. PubMed ID: 23489450
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Bleeding complications of anticoagulant therapy].
    Gumulec J; Kessler P; Procházka V; Brejcha M; Penka M; Zänger M; Machytka E; Klement P
    Vnitr Lek; 2009 Mar; 55(3):277-89. PubMed ID: 19378860
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potential antidotes for reversal of old and new oral anticoagulants.
    Suryanarayan D; Schulman S
    Thromb Res; 2014 May; 133 Suppl 2():S158-66. PubMed ID: 24862137
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.